1. Provide the citation and attach a pdf of the article

• Cordera, R., Pinducciu, C., & Maggi, D. (2020). Type 1 diabetes and technology at time of COVID‐19: A case report. European Journal of Clinical Investigation, 50(8). doi:10.1111/eci.13290
• PDF FILE: type1

2. What is the abstract of the article?

• Background: “Intermittent acute illness contributes to blood glucose dysregulation in Patients with type 1 diabetes mellitus (T1DM): systemic inflammation, insulin resistance, unpredictable eating, fever, nausea, and vomiting, among other factors lead to blood glucose instability with a significant risk of hypoglycemia and represent a difficult challenge for Patients.”
• Methods: “COVID-19 is a recent pandemic disease due to infection
  with SARS-CoV-2 virus, whose clinical course can be very serious.
  In observational trials on COVID-19, hyperglycemia and diabetes are associated with a negative prognosis. Here, we describe the successful glucose control obtained by
  MINIMED 670G in a Patient with T1DM and COVID-19”
• Results: “Data are presented as the mean hourly glucose concentration and time in range (shaded area). It is evident that even in the worst condition Minimed 670G maintained excellent and stable glucose control.”
• Conclusion: “When confirmed by other experiences, automated glucose control should be offered to all Patients with T1DM as the best available insulin
  therapy, not only looking at “time in control” but also at glucose response to stress events.”

3. Was the study experimental or non-experimental?

• The research was experimental as a patient with type 1 diabetes was given a MINIMED 670G as a treatment to figure out how it may affect it with COVID-19.

4. Was the research qualitative or quantitative?

• The research conducted was qualitative because everything in the research study was being experimented, written down, and examined to see how they would interact with each other.

5. What was the population studied? 

• One female with both diabetes and COVID.

6. What sample was used for this study?

• The sample used for this study was a patient who had both diabetes and COVID while she was experiencing  severe symptoms.

7. What was the method of measurement?

• The patients temperature during the experiment
• Her blood glucose levels
• Her health conditions ie. nausea, fatigue, taste.

8. What was the method of analysis? 

• Real-Time data was the method of analysis as she was being closely watched and monitored making sure her health was rising and not declining.

9. What was the conclusion of the study?

• The conclusion of the study was that MINIMED 670G infused in insulin worked optimally as it maintained her glucose level at a perfect rate, we also learned her stress levels were well balanced.

10. Why is this study useful to you? Explain in detail

• I found this study interesting because my dad currently has type 1 diabetes and was wondering how this may play a role with COVID-19. I learned that even though there is a tough battle to fight against COVID, there are ways his diabetes could be controlled and not obstructing his conditions even more.

11. What would be the next logical step in extending this study?

• Since the results proved to work the next logical extension would be to get this practice out to patients who need it and monitor their health. If it did fail in any case, they could take it apart and see where and what happened to cause that.